Initial impact of drug-eluting stents on coronary artery bypass graft surgery.
暂无分享,去创建一个
[1] Lippincott Williams Wilkins,et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery , 2004 .
[2] Gregg W Stone,et al. One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial , 2004, Circulation.
[3] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[4] N. Karajić. Enterprise in Transition , 1996 .
[5] A. Marks,et al. Drug-eluting stents. , 2004, Annual review of medicine.
[6] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Journal of the American College of Cardiology.